Substituted pyrimido[1,2-a]azepines useful as HIV integrase...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S579000, C540S476000, C514S259400, C514S259410, C544S282000

Reexamination Certificate

active

07414045

ABSTRACT:
Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula (A): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1, 2 or 3, and R1, R3, R4, R12, R14, R16, R30, R32, R34and R36are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

REFERENCES:
patent: 6262055 (2001-07-01), Young et al.
patent: 6306891 (2001-10-01), Selnick et al.
patent: 6380249 (2002-04-01), Young et al.
patent: 7169780 (2007-01-01), Crescenzi et al.
patent: 2003/0055071 (2003-03-01), Anthony et al.
patent: 2004/0106627 (2004-06-01), Gardelli et al.
patent: 2004/0110804 (2004-06-01), Walker et al.
patent: 2004/0204498 (2004-10-01), Walker et al.
patent: 2004/0229892 (2004-11-01), Naidu et al.
patent: 2004/0229909 (2004-11-01), Kiyama et al.
patent: 2005/0025774 (2005-02-01), Crescenzi et al.
patent: 2005/0075356 (2005-04-01), DiFrancesco et al.
patent: 2005/0119482 (2005-06-01), Egbertson et al.
patent: 2006/0258860 (2006-11-01), Crescenzi et al.
patent: WO 01/00578 (2001-01-01), None
patent: WO 01/94351 (2001-12-01), None
patent: WO 02/06246 (2002-01-01), None
patent: WO 02/30426 (2002-04-01), None
patent: WO 02/30930 (2002-04-01), None
patent: WO 02/36734 (2002-05-01), None
patent: WO 02/055079 (2002-07-01), None
patent: WO 03/016275 (2003-02-01), None
patent: WO 03/035076 (2003-05-01), None
patent: WO 03/035077 (2003-05-01), None
patent: WO 03/062204 (2003-07-01), None
Ratner, L., et al., “Complete Nucleotide Sequence of the AIDS Virus, HTLV-III”, Nature, vol. 313, pp. 277-284, (1985).
Toh, H., et al., “Close Structural Resemblance Between Putative Polymerase of a Drosphila Transposable Genetic Element 17.6 and Pol Gene Product of Moloney Murine Leukemia Virus”, EMBO Journal, vol. 4, No. 5, pp. 1267-1272, (1985).
Power, M.D., et al., “Nucleotide Sequence of SRV-1, a Type D Simian Acquired Immune Deficiency Syndrome Retrovirus”, Science, vol. 231, pp. 1567-1572, (1986).
Pearl, L.H., et al., “A Structural Model for the Retroviral Proteases”, Nature, vol. 329, pp. 351-354, (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted pyrimido[1,2-a]azepines useful as HIV integrase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrimido[1,2-a]azepines useful as HIV integrase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrimido[1,2-a]azepines useful as HIV integrase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4012829

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.